Helicobacter pylori-Induced Progranulin Promotes the Progression of the Gastric Epithelial Cell Cycle by Regulating CDK4

다국어 초록 (Multilingual Abstract)

Helicobacter pylori, a group 1 carcinogen, colonizes the stomach and affects the development of stomach diseases. Progranulin (PGRN) is an autocrine growth factor that regulates multiple cellular processes and plays a tumorigenic role in many tissues. Nevertheless, the mechanism of action of PGRN in gastric cancer caused by H. pylori infection remains unclear. Here, we investigated the role of PGRN in cell cycle progression and the cell proliferation induced by H. pylori infection. We found that the increased PGRN was positively associated with CDK4 expression in gastric cancer tissue.
PGRN was upregulated by H. pylori infection, thereby promoting cell proliferation, and that enhanced level of proliferation was reduced by PGRN inhibitor. CDK4, a target gene of PGRN, is a cyclin-dependent kinase that binds to cyclin D to promote cell cycle progression, which was upregulated by H. pylori infection. We also showed that knockdown of CDK4 reduced the higher cell cycle progression caused by upregulated PGRN. Moreover, when the PI3K/Akt signaling pathway (which is promoted by PGRN) was blocked, the upregulation of CDK4 mediated by PGRN was reduced. These results reveal the potential mechanism by which PGRN plays a major role through CDK4 in the pathological mechanism of H. pylori infection.

참고문헌 (Reference)

1 Nianshuang Li, "p53, a potential predictor ofHelicobacter pyloriinfection-associated gastric carcinogenesis?" Impact Journals, LLC 7 (7): 66276-66286, 2016

2 Wang H, "Upregulation of progranulin by Helicobacter pylori in human gastric epithelial cells via p38MAPK and MEK1/2 signaling pathway : role in epithelial cell proliferation and migration" 63 : 82-92, 2011

3 Kato MV, "Up-regulation of cell cycle-associated genes by p53 in apoptosis of an erythroleukemic cell line" 11 (11): 389-392, 1997

4 Kar S, "Unraveling cell-cycle dynamics in cancer" 2 : 8-10, 2016

5 Campbell GJ, "The role of CDKs and CDKIs in murine development" 21 : 5343-, 2020

6 Kollmann K, "The interplay of CDK4 and CDK6 in melanoma" 10 : 1346-1359, 2019

7 Tang W, "The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice" 332 : 478-484, 2011

8 Wu JY, "The eradication of Helicobacter pylori to prevent gastric cancer : a critical appraisal" 13 : 17-24, 2019

9 Pack LR, "Putting the brakes on the cell cycle : mechanisms of cellular growth arrest" 60 : 106-113, 2019

10 Evan GI, "Proliferation, cell cycle and apoptosis in cancer" 411 : 342-348, 2001

11 Zheyu Song, "Progress in the treatment of advanced gastric cancer" IOS Press 39 (39): 101042831771462-, 2017

12 Buraschi S, "Progranulin/EphA2 axis : A novel oncogenic mechanism in bladder cancer" 93 : 10-24, 2020

13 He Z, "Progranulin(PC-cell-derived growth factor/acrogranin)regulates invasion and cell survival" 62 : 5590-5596, 2002

14 Serrero G, "Progranulin(GP88)tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma" 14 : R26-, 2012

15 Walsh CE, "Progranulin regulates neurogenesis in the developing vertebrate retina" 77 : 1114-1129, 2017

16 Wei J, "Progranulin promotes diabetic fracture healing in mice with type 1diabetes" 1460 : 43-56, 2020

17 Yang D, "Progranulin promotes colorectal cancer proliferation and angiogenesis through TNFR2/Akt and ERK signaling pathways" 5 : 3085-3097, 2015

18 He Z, "Progranulin is a mediator of the wound response" 9 : 225-229, 2003

19 Fang W, "Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages(TAMs)and promoting CD8(+)T cell exclusion" 40 : 4-, 2021

20 Yabe K, "Progranulin depletion inhibits proliferation via the transforming growth factor beta/SMAD family member 2 signaling axis in Kasumi-1 cells" 7 : e05849-, 2021

21 Arechavaleta-Velasco F, "Progranulin and its biological effects in cancer" 34 : 194-, 2017

22 Lu J, "Progranulin ameliorates lung inflammation in an LPS-induced acute lung injury mouse model by modulating macrophage polarization and the MAPK pathway" 51 : 220-230, 2021

23 Demorrow S, "Progranulin : a novel regulator of gastrointestinal cancer progression" 2 : 145-151, 2013

24 Jian J, "Progranulin : A key player in autoimmune diseases" 101 : 48-55, 2018

25 Dong T, "PGRN promotes migration and invasion of epithelial ovarian cancer cells through an epithelial mesenchymal transition program and the activation of cancer associated fibroblasts" 100 : 17-25, 2016

26 Alquezar C, "PGRN haploinsufficiency increased Wnt5a signaling in peripheral cells from frontotemporal lobar degeneration-progranulin mutation carriers" 35 : 886-898, 2014

27 Li H, "PGRN exerts inflammatory effects via SIRT1-NF-kappaB in adipose insulin resistance" 64 : 181-193, 2020

28 Wang W, "PC cell-derived growth factor(granulin precursor)expression and action in human multiple myeloma" 9 : 2221-2228, 2003

29 Chinzei N, "P21 deficiency delays regeneration of skeletal muscular tissue" 10 : e0125765-, 2015

30 Molaei F, "Molecular signaling in tumorigenesis of gastric cancer" 22 : 217-230, 2018

31 Enders GH, "Mammalian interphase cdks : dispensable master regulators of the cell cycle" 3 : 614-618, 2012

32 Jackson RJ, "Loss of the cell cycle inhibitors p21(Cip1)and p27(Kip1)enhances tumorigenesis in knockout mouse models" 21 : 8486-8497, 2002

33 Lu R, "Inhibition of PC cell-derived growth factor(PCDGF, epithelin/granulin precursor)expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468" 97 : 3993-3998, 2000

34 Cover TL, "Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin" 63 : 951-957, 2003

35 Canepa ET, "INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions" 59 : 419-426, 2007

36 Schistosomes, "IARC Working Group on the Evaluation of Carcinogenic Risks to Humans" 61 : 7-14, 1994

37 Kimura A, "Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis" 137 : 455-462, 2018

38 Wang F, "Helicobacter pylori-induced gastric inflammation and gastric cancer" 345 : 196-202, 2014

39 Kyung-Mi Kim ; Seung-Gyu Lee ; Jung-Min Kim ; Do-Su Kim ; Jea-Young Song ; Hyung-Lyun Kang ; Woo-Kon Lee ; Myung-Je Cho ; Kwang-Ho Rhee ; 윤희상 ; Seung-Chul Baik, "Helicobacter pylori γ-Glutamyltranspeptidase Induces Cell Cycle Arrest at the G1-S Phase Transition" 한국미생물학회 48 (48): 372-377, 2010

40 Shirin H, "Helicobacter pylori inhibits the G1 to S transition in AGS gastric epithelial cells" 59 : 2277-2281, 1999

41 Ahmed A, "Helicobacter pylori inhibits gastric cell cycle progression" 2 : 1159-1169, 2000

42 Huanying Li ; Dongsheng Liang ; Naiming Hu ; Xingzhu Dai ; Jianing He ; Hongmin Zhuang ; Wanghong Zhao, "Helicobacter pylori inhibited cell proliferation in human periodontal ligament fibroblasts through the Cdc25C/CDK1/cyclinB1 signaling cascade" 대한치주과학회 49 (49): 138-147, 2019

43 Gonzalez CA, "Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study : the Eurgast-EPIC project" 23 : 1320-1324, 2012

44 Megraud F, "Helicobacter pylori infection and gastric carcinoma" 21 : 984-990, 2015

45 Ford AC, "Helicobacter pylori eradication therapy to prevent gastric cancer : systematic review and metaanalysis" 69 : 2113-2121, 2020

46 Richard M. Peek, "Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils" Elsevier BV 118 (118): 48-59, 2000

47 Jaehoon Cho, "Helicobacter pylori Infection" Elsevier BV 50 (50): 261-282, 2021

48 Liu B, "HP-CagA+ regulates the expression of CDK4/CyclinD1 via reg3 to change cell cycle and promote cell proliferation" 21 : 224-, 2019

49 Feng T, "Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway" 7 : 58381-58395, 2016

50 Lu Y, "Growth factor progranulin contributes to cervical cancer cell proliferation and transformation in vivo and in vitro" 134 : 364-371, 2014

51 Ho JC, "Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma" 47 : 1524-1532, 2008

52 Feng JQ, "Granulin epithelin precursor : a bone morphogenic protein 2-inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis" 24 : 1879-1892, 2010

53 Klupp F, "Granulin : an invasive and survival-determining marker in colorectal cancer patients" 22 : 6436-, 2021

54 Hooi JKY, "Global prevalence of Helicobacter pylori infection : Systematic review and meta-analysis" 153 : 420-429, 2017

55 Sung H, "Global Cancer Statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" 71 : 209-249, 2021

56 Karimi P, "Gastric cancer : descriptive epidemiology, risk factors, screening, and prevention" 23 : 700-713, 2014

57 Zhou Z, "Expression of Wnt3, beta-catenin and MMP-7 in gastric cancer and precancerous lesions and their correlations with Helicobacter pylori infection" 46 : 575-582, 2021

58 Abdulrahman A, "Expression of GP88(Progranulin)protein is an independent prognostic factor in prostate cancer patients" 11 : 2029-, 2019

59 Zhao J, "Effect of progranulin on migration and invasion of human colon cancer cells" 28 : 607-611, 2018

60 Fong LY, "Early deregulation of the the p16ink4a-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway in cell proliferation-driven esophageal tumorigenesis in zinc-deficient rats" 60 : 4589-4595, 2000

61 Sherr CJ, "D-type cyclins" 20 : 187-190, 1995

62 Tadesse S, "Cyclin-eependent kinase 2 inhibitors in cancer therapy : An update" 62 : 4233-4251, 2019

63 Hochegger H, "Cyclin-dependent kinases and cell-cycle transitions : does one fit all?" 9 : 910-916, 2008

64 Gao X, "Cyclin D-CDK4/6 functions in cancer" 148 : 147-169, 2020

65 Teo ZL, "Combined CDK4/6 and PI3Kalpha inhibition is synergistic and immunogenic in triple-negative breast cancer" 77 : 6340-6352, 2017

66 Scotti C, "Cell-cycle inhibition by Helicobacter pylori Lasparaginase" 5 : e13892-, 2010

67 Kastan MB, "Cell-cycle checkpoints and cancer" 432 : 316-323, 2004

68 Sherr CJ, "Cancer cell cycles" 274 : 1672-1677, 1996

69 Heide L. Ford, "Cancer and the cell cycle" Wiley 75 (75): 166-172, 1999

70 Woodward TA, "Barrett's esophagus, apoptosis and cell cycle regulation : correlation of p53with Bax, Bcl-2 and p21 protein expression" 20 : 2427-2432, 2000

71 Padda J, "Association between Helicobacter pylori and gastric carcinoma" 13 : e15165-, 2021

72 Guha R, "Anti-progranulin/GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration" 186 : 637-653, 2021

73 Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))method" 25 : 402-408, 2001

74 Carolina Alquezar, "Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709-1G>A PGRN mutation associated with FTLD-TDP dementia" Elsevier BV 33 (33): 429.e7-429.e20, 2012

75 Xu B, "Abnormal angiogenesis of placenta in progranulindeficient mice" 22 : 3482-3492, 2020

76 Zhou C, "A narrative review of multiple mechanisms of progranulin in cancer : a potential target for anti-cancer therapy" 10 : 4207-4216, 2021